{"id":2131,"date":"2026-09-02T07:07:00","date_gmt":"2026-09-02T07:07:00","guid":{"rendered":"https:\/\/cumcura.be\/?p=2131"},"modified":"2026-09-25T18:21:01","modified_gmt":"2026-09-25T18:21:01","slug":"260902-1","status":"publish","type":"post","link":"https:\/\/cumcura.be\/en\/260902-1\/","title":{"rendered":"Leuven research on a new generation of sarcoma drugs"},"content":{"rendered":"<div class=\"et_pb_section_0 et_pb_section et_section_regular et_block_section\">\n<div class=\"et_pb_row_0 et_pb_row et_block_row\">\n<div class=\"et_pb_column_0 et_pb_column et_pb_column_4_4 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_0 et_pb_text et_pb_bg_layout_light et_clickable et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><h4 data-start=\"296\" data-end=\"556\"><strong><span>Promising, but still at an early stage<\/span><\/strong><\/h4>\n<p data-start=\"296\" data-end=\"556\">Researchers from KU Leuven and UZ Leuven have published new results on two experimental drugs against soft tissue sarcoma: <em>ecubectedin<\/em> and <em>PM54<\/em>Both are closely related to trabectedin (Yondelis), a drug already used today for advanced sarcoma when previous chemotherapy has not been sufficiently effective.<\/p>\n<p>This research was carried out in the laboratory, using mouse models into which human tumour tissue had been implanted. It is therefore explicitly preclinical research: an important intermediate step, but not yet a treatment available to patients.<\/p>\n<p>The researchers tested six tumour models, divided across four subtypes. For the more \u201ccomplex\u201d sarcomas, leiomyosarcoma and dedifferentiated liposarcoma, the effect was modest and comparable to existing drugs. The most striking result was seen in the two so-called translocation-driven sarcomas: <strong>s<\/strong>synovial sarcoma and the rare and aggressive CIC-rearranged sarcoma. In these two cases, the new drugs inhibited or reduced the tumours markedly more strongly than trabectedin. In the CIC-rearranged sarcoma, the tumour even shrank noticeably, and in synovial sarcoma, stabilisation persisted for several weeks after the last dose.<\/p>\n<p>For now, this is mainly encouraging fundamental research that opens the door to further study. The drugs are still in the early phases of clinical trials in humans, and it is not yet known whether, and in whom, they will ultimately be effective and safe. It is therefore not a reason for concrete expectations in the short term, but it is a development that we, as a community, will continue to follow with interest.<\/p>\n<p>That this work comes from a Belgian laboratory underlines how important sarcoma research close to home is. It was made possible in part by patients who donated tissue for scientific research.<\/p>\n<p>More information <a href=\"https:\/\/aacrjournals.org\/cancerrescommun\/article\/doi\/10.1158\/2767-9764.CRC-26-0377\/787447\/Antitumor-activity-of-novel-transcriptional\" target=\"_blank\" rel=\"noopener\">paper<\/a><\/p>\n<p>---------------------------<br \/><em>Source: Gorgels et al., Cancer Research Communications (2026), open access \u2014 DOI 10.1158\/2767-9764.CRC-26-0377. <\/em><em>The study was partly funded by PharmaMar, the developer of these drugs.<\/em><\/p>\n<p><strong>Translocation-driven sarcoma:<\/strong><br \/>a tumour driven by one specific DNA error: two pieces of chromosome incorrectly join together, forming an abnormal \u201cfusion gene\u201d that drives cancer growth. This contrasts with \u201ccomplex\u201d sarcomas, which arise from many different, scattered chromosomal abnormalities. Tumours that depend on a single central error often prove more sensitive to drugs that disrupt precisely that gene transcription process.<\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Researchers from KU Leuven and UZ Leuven have published new results on two experimental drugs against soft tissue sarcoma: <\/p>","protected":false},"author":1,"featured_media":2335,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[172],"tags":[187],"class_list":["post-2131","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-wetenschap","tag-cumcuravzw"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen - Cum Cura<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cumcura.be\/en\/260902-1\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen - Cum Cura\" \/>\n<meta property=\"og:description\" content=\"Onderzoekers van de KU Leuven en UZ Leuven publiceerden nieuwe resultaten over twee experimentele geneesmiddelen tegen wekedelensarcoom: ecubectedin en PM54.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cumcura.be\/en\/260902-1\/\" \/>\n<meta property=\"og:site_name\" content=\"Cum Cura\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CumCuraVZW\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T07:07:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-25T18:21:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cumcura.be\/wp-content\/uploads\/2026\/09\/BLOG-Onderzoek-sarcoma1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cumcura\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cumcura\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/\"},\"author\":{\"name\":\"cumcura\",\"@id\":\"https:\\\/\\\/cumcura.be\\\/en\\\/#\\\/schema\\\/person\\\/a97c38cd9274b99d1c1ec67dcd007223\"},\"headline\":\"Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen\",\"datePublished\":\"2026-09-02T07:07:00+00:00\",\"dateModified\":\"2026-09-25T18:21:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/\"},\"wordCount\":7,\"publisher\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/cumcura.be\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/BLOG-Onderzoek-sarcoma1-scaled.jpg?fit=2560%2C1626&ssl=1\",\"keywords\":[\"cumcuravzw\"],\"articleSection\":[\"Wetenschap\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/\",\"url\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/\",\"name\":\"Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen - Cum Cura\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/cumcura.be\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/BLOG-Onderzoek-sarcoma1-scaled.jpg?fit=2560%2C1626&ssl=1\",\"datePublished\":\"2026-09-02T07:07:00+00:00\",\"dateModified\":\"2026-09-25T18:21:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/cumcura.be\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/BLOG-Onderzoek-sarcoma1-scaled.jpg?fit=2560%2C1626&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/cumcura.be\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/BLOG-Onderzoek-sarcoma1-scaled.jpg?fit=2560%2C1626&ssl=1\",\"width\":2560,\"height\":1626},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cumcura.be\\\/260902-1\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cumcura.be\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cumcura.be\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/cumcura.be\\\/en\\\/\",\"name\":\"Cum Cura\",\"description\":\"Kanker met zorg\",\"publisher\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cumcura.be\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cumcura.be\\\/en\\\/#organization\",\"name\":\"Cum Cura\",\"url\":\"https:\\\/\\\/cumcura.be\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/cumcura.be\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cumcura.be\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/CUMCURA_LOGO_CLEAN_CMYK.png\",\"contentUrl\":\"https:\\\/\\\/cumcura.be\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/CUMCURA_LOGO_CLEAN_CMYK.png\",\"width\":1772,\"height\":975,\"caption\":\"Cum Cura\"},\"image\":{\"@id\":\"https:\\\/\\\/cumcura.be\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CumCuraVZW\\\/\",\"https:\\\/\\\/www.instagram.com\\\/cumcuravzw\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cumcura.be\\\/en\\\/#\\\/schema\\\/person\\\/a97c38cd9274b99d1c1ec67dcd007223\",\"name\":\"cumcura\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec15a7ad3a8732673257affa1a76d0d30be8a13f0d789ab5f742f147dec849df?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec15a7ad3a8732673257affa1a76d0d30be8a13f0d789ab5f742f147dec849df?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec15a7ad3a8732673257affa1a76d0d30be8a13f0d789ab5f742f147dec849df?s=96&d=mm&r=g\",\"caption\":\"cumcura\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen - Cum Cura","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cumcura.be\/en\/260902-1\/","og_locale":"en_GB","og_type":"article","og_title":"Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen - Cum Cura","og_description":"Onderzoekers van de KU Leuven en UZ Leuven publiceerden nieuwe resultaten over twee experimentele geneesmiddelen tegen wekedelensarcoom: ecubectedin en PM54.","og_url":"https:\/\/cumcura.be\/en\/260902-1\/","og_site_name":"Cum Cura","article_publisher":"https:\/\/www.facebook.com\/CumCuraVZW\/","article_published_time":"2026-09-02T07:07:00+00:00","article_modified_time":"2026-09-25T18:21:01+00:00","og_image":[{"width":2560,"height":1626,"url":"https:\/\/cumcura.be\/wp-content\/uploads\/2026\/09\/BLOG-Onderzoek-sarcoma1-scaled.jpg","type":"image\/jpeg"}],"author":"cumcura","twitter_card":"summary_large_image","twitter_misc":{"Written by":"cumcura","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cumcura.be\/260902-1\/#article","isPartOf":{"@id":"https:\/\/cumcura.be\/260902-1\/"},"author":{"name":"cumcura","@id":"https:\/\/cumcura.be\/en\/#\/schema\/person\/a97c38cd9274b99d1c1ec67dcd007223"},"headline":"Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen","datePublished":"2026-09-02T07:07:00+00:00","dateModified":"2026-09-25T18:21:01+00:00","mainEntityOfPage":{"@id":"https:\/\/cumcura.be\/260902-1\/"},"wordCount":7,"publisher":{"@id":"https:\/\/cumcura.be\/en\/#organization"},"image":{"@id":"https:\/\/cumcura.be\/260902-1\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/cumcura.be\/wp-content\/uploads\/2026\/09\/BLOG-Onderzoek-sarcoma1-scaled.jpg?fit=2560%2C1626&ssl=1","keywords":["cumcuravzw"],"articleSection":["Wetenschap"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/cumcura.be\/260902-1\/","url":"https:\/\/cumcura.be\/260902-1\/","name":"Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen - Cum Cura","isPartOf":{"@id":"https:\/\/cumcura.be\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cumcura.be\/260902-1\/#primaryimage"},"image":{"@id":"https:\/\/cumcura.be\/260902-1\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/cumcura.be\/wp-content\/uploads\/2026\/09\/BLOG-Onderzoek-sarcoma1-scaled.jpg?fit=2560%2C1626&ssl=1","datePublished":"2026-09-02T07:07:00+00:00","dateModified":"2026-09-25T18:21:01+00:00","breadcrumb":{"@id":"https:\/\/cumcura.be\/260902-1\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cumcura.be\/260902-1\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cumcura.be\/260902-1\/#primaryimage","url":"https:\/\/i0.wp.com\/cumcura.be\/wp-content\/uploads\/2026\/09\/BLOG-Onderzoek-sarcoma1-scaled.jpg?fit=2560%2C1626&ssl=1","contentUrl":"https:\/\/i0.wp.com\/cumcura.be\/wp-content\/uploads\/2026\/09\/BLOG-Onderzoek-sarcoma1-scaled.jpg?fit=2560%2C1626&ssl=1","width":2560,"height":1626},{"@type":"BreadcrumbList","@id":"https:\/\/cumcura.be\/260902-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cumcura.be\/"},{"@type":"ListItem","position":2,"name":"Leuvens onderzoek naar een nieuwe generatie sarcoomgeneesmiddelen"}]},{"@type":"WebSite","@id":"https:\/\/cumcura.be\/en\/#website","url":"https:\/\/cumcura.be\/en\/","name":"Cum Cura","description":"Cancer with care","publisher":{"@id":"https:\/\/cumcura.be\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cumcura.be\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/cumcura.be\/en\/#organization","name":"Cum Cura","url":"https:\/\/cumcura.be\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cumcura.be\/en\/#\/schema\/logo\/image\/","url":"https:\/\/cumcura.be\/wp-content\/uploads\/2018\/11\/CUMCURA_LOGO_CLEAN_CMYK.png","contentUrl":"https:\/\/cumcura.be\/wp-content\/uploads\/2018\/11\/CUMCURA_LOGO_CLEAN_CMYK.png","width":1772,"height":975,"caption":"Cum Cura"},"image":{"@id":"https:\/\/cumcura.be\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CumCuraVZW\/","https:\/\/www.instagram.com\/cumcuravzw\/"]},{"@type":"Person","@id":"https:\/\/cumcura.be\/en\/#\/schema\/person\/a97c38cd9274b99d1c1ec67dcd007223","name":"cumcura","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/ec15a7ad3a8732673257affa1a76d0d30be8a13f0d789ab5f742f147dec849df?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ec15a7ad3a8732673257affa1a76d0d30be8a13f0d789ab5f742f147dec849df?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ec15a7ad3a8732673257affa1a76d0d30be8a13f0d789ab5f742f147dec849df?s=96&d=mm&r=g","caption":"cumcura"}}]}},"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/cumcura.be\/wp-content\/uploads\/2026\/09\/BLOG-Onderzoek-sarcoma1-scaled.jpg?fit=2560%2C1626&ssl=1","_links":{"self":[{"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/posts\/2131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/comments?post=2131"}],"version-history":[{"count":6,"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/posts\/2131\/revisions"}],"predecessor-version":[{"id":2331,"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/posts\/2131\/revisions\/2331"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/media\/2335"}],"wp:attachment":[{"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/media?parent=2131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/categories?post=2131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cumcura.be\/en\/wp-json\/wp\/v2\/tags?post=2131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}